K. Newbold

New England Journal of Medicine · 2011–2019

A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from K. Newbold's perspective

Ordered by how strongly the researchers K. Newbold trusts endorse each paper. Same corpus, a different order for every researcher.

  1. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. (European Journal of Endocrinology)
  2. Extent of Surgery Affects Survival for Papillary Thyroid Cancer (Annals of Surgery)
  3. Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: a randomized, double-blind, phase 3 trial (The Lancet)
  4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). (European Journal of Cancer)
  5. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. (New England Journal of Medicine)
  6. Guidelines for radioiodine therapy of differentiated thyroid cancer (European Journal of Nuclear Medicine and Molecular Imaging)
  7. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. (New England Journal of Medicine)
  8. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma (JAMA Oncology)
  9. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. (Clinical Infectious Diseases)
  10. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. (Journal of Clinical Oncology)

Their papers